Sign inGet started

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Insider CIK 2080343 · KLRA 10% owner · BRVE 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BRVE Braveheart Bio, Inc. C Conversion deriv2026-08-072026-08-1032,500,000— $00SEC↗
BRVE Braveheart Bio, Inc. C Conversion2026-08-072026-08-107,420,091— $07,420,091SEC↗
BRVE Braveheart Bio, Inc. C Conversion deriv2026-08-072026-08-1032,500,000— $00SEC↗
BRVE Braveheart Bio, Inc. C Conversion2026-08-072026-08-107,420,091— —7,420,091SEC↗
KLRA Kailera Therapeutics, Inc. C Conversion deriv2026-04-202026-04-22708,814— $00SEC↗
KLRA Kailera Therapeutics, Inc. C Conversion deriv2026-04-202026-04-224,968,789— $00SEC↗
KLRA Kailera Therapeutics, Inc. C Conversion2026-04-202026-04-229,477,719— $09,477,719SEC↗
KLRA Kailera Therapeutics, Inc. C Conversion2026-04-202026-04-222,034,133— $02,034,133SEC↗